Real-world Pharmacovigilance Analysis and Mechanistic Exploration of JAK Inhibitor-Associated Skin Tumor Risk Using FAERS, VigiBase, and Network Pharmacology
Description
Supplementary Figures Online-Only: Supplementary Figures 1–8 for "Real-world Pharmacovigilance Analysis and Mechanistic Exploration of JAK Inhibitor-Associated Skin Tumor Adverse Events Using FAERS, VigiBase, and Network Pharmacology" provide a more detailed explanation of the results in the paper, and their numbering corresponds to the figure numbers in the main text. Supplementary Materials Online-Only: Methods, limitations, and supplementary tables of “Real-world Pharmacovigilance Analysis and Mechanistic Exploration of JAK Inhibitor-Associated Skin Tumor Adverse Events Using FAERS, VigiBase, and Network Pharmacology”, provide a more detailed explanation of the results in the paper, and their numbering corresponds to the table numbers in the main text.